STAAR Surgical Company
STAA
$18.84
$0.452.45%
NASDAQ
| 01/02/2026 | 09/26/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -38.98% | 113.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -38.98% | 113.75% | |||
| Cost of Revenue | -16.59% | 46.32% | |||
| Gross Profit | -43.83% | 137.43% | |||
| SG&A Expenses | 2.81% | -6.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.17% | 1.82% | |||
| Operating Income | -144.51% | 199.38% | |||
| Income Before Tax | -209.91% | 172.51% | |||
| Income Tax Expenses | -123.65% | 208.82% | |||
| Earnings from Continuing Operations | -306.09% | 152.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -306.09% | 152.84% | |||
| EBIT | -144.51% | 199.38% | |||
| EBITDA | -133.58% | 216.86% | |||
| EPS Basic | -305.59% | 152.72% | |||
| Normalized Basic EPS | -135.27% | 219.48% | |||
| EPS Diluted | -305.59% | 152.65% | |||
| Normalized Diluted EPS | -135.93% | 217.29% | |||
| Average Basic Shares Outstanding | 0.25% | 0.23% | |||
| Average Diluted Shares Outstanding | -1.56% | 2.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||